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ABSTRACT Recently, two inﬂuenza A virus (FLUAV) genomes were identiﬁed in
Central and South American bats. These sequences exhibit notable divergence from
classical FLUAV counterparts, and functionally, bat FLUAV glycoproteins lack canoni-
cal receptor binding and destroying activity. Nevertheless, other features that distin-
guish these viruses from classical FLUAVs have yet to be explored. Here, we studied
the viral nonstructural protein NS1, a virulence factor that modulates host signaling
to promote efﬁcient propagation. Like all FLUAV NS1 proteins, bat FLUAV NS1s bind
double-stranded RNA and act as interferon antagonists. Unexpectedly, we found that
bat FLUAV NS1s are unique in being unable to bind host p85, a regulatory subunit
of the cellular metabolism-regulating enzyme, phosphoinositide 3-kinase (PI3K). Fur-
thermore, neither bat FLUAV NS1 alone nor infection with a chimeric bat FLUAV efﬁ-
ciently activates Akt, a PI3K effector. Structure-guided mutagenesis revealed that the
bat FLUAV NS1-p85 interaction can be reengineered (in a strain-speciﬁc manner)
by changing two to four NS1 residues (96L, 99M, 100I, and 145T), thereby creating a
hydrophobic patch. Notably, ameliorated p85-binding is insufﬁcient for bat FLUAV
NS1 to activate PI3K, and a chimeric bat FLUAV expressing NS1 with engineered hy-
drophobic patch mutations exhibits cell-type-dependent, but species-independent,
propagation phenotypes. We hypothesize that bat FLUAV hijacking of PI3K in the
natural bat host has been selected against, perhaps because genes in this meta-
bolic pathway were differentially shaped by evolution to suit the unique energy
use strategies of this ﬂying mammal. These data expand our understanding of
the enigmatic functional divergence between bat FLUAVs and classical mamma-
lian and avian FLUAVs.
IMPORTANCE The potential for novel inﬂuenza A viruses to establish infections in
humans from animals is a source of continuous concern due to possible severe out-
breaks or pandemics. The recent discovery of inﬂuenza A-like viruses in bats has
raised questions over whether these entities could be a threat to humans. Under-
standing unique properties of the newly described bat inﬂuenza A-like viruses, such
as their mechanisms to infect cells or how they manipulate host functions, is critical
to assess their likelihood of causing disease. Here, we characterized the bat inﬂuenza
A-like virus NS1 protein, a key virulence factor, and found unexpected functional di-
vergence of this protein from counterparts in other inﬂuenza A viruses. Our study
dissects the molecular changes required by bat inﬂuenza A-like virus NS1 to adopt
classical inﬂuenza A virus properties and suggests consequences of bat inﬂuenza
A-like virus infection, potential future evolutionary trajectories, and intriguing virus-
host biology in bat species.
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In 2012 and 2013, two novel inﬂuenza A virus (FLUAV) genomes were discovered byreverse transcription-PCR (RT-PCR) analysis of rectal samples from two species of
Guatemalan and Peruvian fruit bats (1, 2). Due to high sequence and evolutionary
divergence in multiple genomic segments compared to other FLUAVs, these viruses
were designated the unique subtypes HL17NL10 and HL18NL11 (1–3). Functional
characterization of bat FLUAVs and their encoded proteins using reverse genetic or
reductionist techniques have since revealed remarkable properties of these viruses
(reviewed in references 3 to 6). For example, bat FLUAV surface glycoproteins lack
canonical receptor binding or destroying features (7–10), and these viruses preferen-
tially enter polarized cells at the basolateral membrane (11). Thus, bat FLUAVs appear
to have evolved unique mechanisms for entering host cells that are distinct from
classical mammalian and avian FLUAVs. Other features that distinguish bat FLUAVs
from other FLUAVs have yet to be explored in detail.
The precise host range and zoonotic potential of bat FLUAVs is unknown, although
depending upon the experimental system used, these viruses can infect cells from an
array of species, including bats, humans, and dogs (11–13). Reassortment of bat FLUAVs
with classical FLUAVs has never been observed in experimental studies (14–16), al-
though a cell-line derived from the bat species Pteropus alecto can support replication
and reassortment of avian, swine, and human FLUAVs (17). In addition, there is
evidence that bat species can be naturally infected with classical FLUAVs: in one study
30% of Ghanaian fruit bats analyzed were seropositive for avian H9 FLUAVs (18), and
the respiratory and gastrointestinal tracts of North American little brown bats harbor
receptors for both avian and mammalian FLUAVs (19). Thus, these data suggest that
bats could represent an additional reservoir for FLUAVs, with the potential to provide
either new gene segments or entire viruses that cross the species barrier with unknown
consequences. Understanding fundamental properties of the newly described bat
FLUAVs, such as their mechanisms to infect cells of certain species and how they
modulate functions of the infected host cell environment, will be critical to assess their
likelihood for causing disease in particular hosts.
We have focused on the nonstructural protein NS1 of bat FLUAVs, which shares only
50% sequence identity with other FLUAV NS1 proteins. NS1 is a multifunctional
virulence factor that can contribute to virus host range and virulence (20, 21). A major
role of NS1 during FLUAV infection is to antagonize the host innate interferon (IFN)
system through multiple mechanisms, some of which appear to be strain dependent
(22–31). We and others have recently demonstrated that bat FLUAV NS1 proteins, like
classical FLUAVs, harbor a structurally and functionally conserved N-terminal double-
stranded RNA-binding domain that is critical for potent IFN antagonism in human cells
(15, 32, 33). The C-terminal effector domain (ED) of bat FLUAV NS1 may play a minor
role in supporting IFN antagonism in vitro (15), possibly by promoting NS1 oligomer-
ization (34–37). However, a striking ﬁnding is that deletion of the bat FLUAV NS1 ED has
minimal impact on viral pathogenesis in a mouse model compared to deletion of this
NS1 domain in a human H1N1 FLUAV (15). This suggests unappreciated functional
differences between the EDs of bat and classical FLUAVs that remain to be explored.
Here, we investigated one such activity of the NS1 ED: modulation of the host
intracellular metabolic environment by binding the p85 regulatory subunit of phos-
phoinositide 3-kinase (PI3K) (38). The NS1 EDs of all classical human and avian FLUAV
strains tested to date bind the inter-SH2 (iSH2) domain of host p85 to activate PI3K
signaling (38–42). This activation generally beneﬁts classical FLUAV replication, since
viruses engineered to express NS1 proteins unable to bind p85 are attenuated for
replication in vitro and for virulence in vivo (38, 43, 44). In this study, we found that bat
FLUAV NS1 proteins uniquely lack the ability to bind host p85 and activate PI3K
signaling. We map the bat FLUAV NS1 ED residues responsible for this atypical binding
phenotype and characterize the impact that artiﬁcial introduction of this property into
a model bat FLUAV has on virus propagation in vitro. Our data reveal an unexpected
functional divergence of bat FLUAV NS1 proteins from classical FLUAV NS1 proteins and
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may suggest that speciﬁc metabolic conditions in the bat host in vivo negate any
requirement for NS1 to evolve to engage with host PI3K signaling in these species.
RESULTS
Bat FLUAV NS1 proteins are unable to bind p85. As part of a larger project to
understand the interplay between FLUAV NS1 proteins and host PI3K, we screened a
panel of different NS1s from various virus strains for their ability to interact with human
p85 or the related isoform, p85. To this end, 293T cells were cotransfected with
plasmids expressing FLAG-tagged human p85 or p85, together with plasmids ex-
pressing V5-tagged glutathione S-transferase (GST) or NS1 proteins from representative
human, swine, avian, and bat strains. Soluble fractions were prepared from cell lysates
at 48 h posttransfection and were subjected to immunoprecipitation with an antibody
raised against the V5 tag. Western blot analysis of the resulting precipitates revealed
that NS1 proteins from human (PR8, H1N1; and Cal/09, pdmH1N1), swine (Sw/Tx/98,
H3N2), and avian (Nig/07, H5N1; and Sh/13, H7N9) strains were all capable of interact-
ing speciﬁcally with human p85, but not p85 (Fig. 1A). Surprisingly, NS1 proteins
from bat FLUAVs (Guat/09, HL17NL10; and Peru/10, HL18NL11) were unable to precip-
itate either p85 or p85 (Fig. 1B). This phenotype has not previously been observed
for a naturally occurring FLUAV NS1 protein but is akin to the more distantly related
inﬂuenza B virus (FLUBV) NS1, which is also unable to bind PI3K subunits (45, 46).
Bat FLUAV NS1 proteins do not show a species-speciﬁc interaction with p85.
To examine whether the interaction between bat FLUAV NS1 proteins and host p85
is species speciﬁc, we generated an expression vector for bat (Myotis lucifugus) p85
and assessed its coimmunoprecipitation with various NS1 proteins. Although PR8/NS1
interacted with this bat p85 to an extent similar to human p85, neither the Guat/09
nor the Peru/10 bat FLUAV NS1 proteins were able to precipitate bat p85 (Fig. 2A). To
exclude the possibility that this lack of p85-binding was due to M. lucifugus not being
the primary bat host species for bat FLUAVs, we sought to generate expression vectors
mimicking p85 from the bat species Sturnia lilium (in which the HL17NL10 virus
FIG 1 Strain-speciﬁc interaction of FLUAV NS1 proteins with human p85. 293T cells were cotransfected
for 48 h with plasmids expressing the indicated V5-tagged NS1 protein (or GST) and FLAG-tagged human
p85 or p85. After cell lysis, clariﬁcation, and anti-V5 immunoprecipitation, soluble (input) and
pulldown (IP:-V5) fractions were analyzed by SDS-PAGE and Western blotting. (A) Interaction studies of
human (PR8, Cal/09), swine (Sw/Tx/98), and avian (Nig/07, Sh/13) FLUAV NS1 proteins. (B) Interaction
studies of bat (Guat/09, Peru/10) FLUAV NS1 proteins. Data are representative of three independent
experiments.
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genome was ﬁrst discovered [1]) and Carollia perspicillata (in which individual animals
seropositive for HL18NL11 have been identiﬁed [2]). To this end, we cloned and
sequenced the region encoding the p85 iSH2 domain from tissue originally derived
from S. lilium and C. perspicillata. As shown in Fig. 2B, the human and bat p85 iSH2
domains are almost identical, with only ﬁve residue positions that differ. Three of these
differences are conserved in the bat species sequenced (E544, T547, and L550; bat
numbering), whereas two residue positions (605 and 611) differ between the M.
lucifugus p85 iSH2 domain and the two other bat species (Fig. 2B). We therefore
substituted these two residue positions in the M. lucifugus p85 for the respective
FIG 2 Bat FLUAV NS1 proteins do not show a species-speciﬁc interaction with p85. (A) 293T cells were
cotransfected for 48 h with plasmids expressing the indicated V5-tagged NS1 protein (or GST) and FLAG-tagged
human (Homo sapiens, H.s.) or bat (Myotis lucifugus, M.l.) p85. After cell lysis, clariﬁcation, and anti-V5 immuno-
precipitation, soluble (input) and pulldown (IP:-V5) fractions were analyzed by SDS-PAGE and Western blotting.
(B) Sequence alignment of iSH2 domains from human and bat p85. Human (H. sapiens), little yellow shouldered
bat (S. lilium), little brown bat (M. lucifugus), and Seba’s short-tailed bat (C. perspicillata) p85 iSH2 domain amino
acid sequences (residues 496 to 614) were aligned. Human/bat differences are highlighted by boxes, and shading
indicates residues differing between bat species. (C) Experiment performed as in panel A, except using the
indicated bat p85 mutants. For panels A and C, the data are representative of three independent experiments.
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residues from C. perspicillata (A605S) or S. lilium (A605S/D611E) and assessed their
abilities to coprecipitate with NS1. However, neither bat p85 variant interacted with
the bat FLUAV NS1 proteins, while their interaction with PR8/NS1 was unaffected (Fig.
2C). These data suggest that the bat FLUAV NS1 proteins have not speciﬁcally evolved
to bind bat p85.
Bat FLUAV is an inefﬁcient activator of PI3K signaling during infection. In contrast
to PR8/NS1, and consistent with their inability to bind p85, isolated expression of the
V5-tagged NS1 proteins from Guat/09 or Peru/10 failed to stimulate phosphorylation of
the downstream effector of PI3K, Akt (Fig. 3A). To assess further the impact of bat
FLUAV infection on host PI3K signaling, we generated recombinant, chimeric bat
FLUAVs possessing the six complete internal gene segments of Guat/09 (variant C3;
chHL17) and modiﬁed HA and NA glycoprotein gene segments from PR8, where the
untranslated regions were replaced by the genome ends and packaging sequences of
the corresponding segments of Guat/09. Within these viruses, we also reengineered the
NS segment to allow expression of different V5-tagged NS1 proteins (from PR8, Guat/09
or Peru/10) separated from Guat/09 nuclear export protein (NEP) by a 2A sequence (Fig.
3B). Immunoprecipitations from infected cell lysates revealed that endogenous p85
could be coprecipitated with V5-PR8/NS1 but not with the V5-tagged NS1 proteins
derived from Guat/09 or Peru/10 (Fig. 3C). In addition, we observed that only the
chimeric bat FLUAV expressing V5-tagged PR8/NS1 efﬁciently led to increased phos-
phorylation of Akt during infection (Fig. 3D). These infection data indicate that addi-
tional bat FLUAV internal gene segment products are unable to compensate bat FLUAV
NS1 for either binding host p85 or activating PI3K.
A small number of amino acid changes can establish an interaction between
bat FLUAV NS1 and p85. We analyzed the crystal structure of the PR8/NS1 ED in
FIG 3 Bat FLUAV is an inefﬁcient activator of PI3K signaling during infection. (A) Serum-starved 1321N1
cells stably expressing the indicated V5-tagged GST or NS1 proteins were lysed, and the levels of the
indicated proteins were analyzed by SDS-PAGE and Western blotting. (B) Schematic representation of
mRNAs generated by wild-type (upper) or engineered (lower) NS segments. SD, splice donor; SA, splice
acceptor; 2A, 2A sequence from porcine teschovirus. (C) HAP-1 cells were infected for 8 h with chHL17
viruses expressing the indicated V5-tagged NS1 proteins at an MOI of 5 PFU/cell. After cell lysis,
clariﬁcation, and anti-V5 immunoprecipitation, soluble (input) and pulldown (IP:-V5) fractions were
analyzed by SDS-PAGE and Western blotting. (D) Serum-starved HAP-1 cells were infected with chHL17
viruses expressing the indicated V5-tagged NS1 proteins at an MOI of 5 PFU/cell. Cells were lysed at 3,
6, and 9 h postinfection, and the levels of the indicated proteins were analyzed by SDS-PAGE and
Western blotting. For panels A, C, and D, the data are representative of at least two independent
experiments.
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complex with the p85 iSH2 domain, taking into account recent mutagenesis data
(Fig. 4A) (41, 47). Of the NS1 residues present at this interface, six were selected for
substitution analysis in the bat FLUAV NS1 proteins based on their divergence from
residues in NS1 proteins with the ability to bind p85 (Fig. 4A and B). Single amino acid
substitutions at these six ED residues in Guat/09 NS1 (Q96L, T99M, I100S, R145T, N163S,
and S166P; Guat/09 NS1 numbering) did not result in the establishment of human p85
binding (Fig. 4C). However, combining the amino acid substitutions Q96L and T99M
resulted in partial p85 binding (Fig. 4D). The interaction between Guat/09 NS1 and
human p85 could be enhanced further when the additional R145T substitution was
introduced (Fig. 4D). Substitutions at other positions (particularly I100S) proved to be
disruptive to the interaction (Fig. 4D). From these data, we infer that creation of a
hydrophobic patch around positions 96, 99, and 100 in the Guat/09 NS1 ED is essential
for determining the interaction with p85. Largely similar, but distinct, results were
obtained for substitution analysis of the Peru/10 NS1 protein: single amino acid
substitution of V96L, T99M, or R145T, as well as double substitution of V96L and T99M,
did not establish an interaction with human p85 (Fig. 5A and B). In fact, only when
N100I was combined with double substitution of V96L and T99M could some weak
p85 binding be observed, which was strongly enhanced by R145T (Fig. 5B). Notably,
mutant Guat/09 and Peru/10 NS1 constructs generated to possess optimal p85
binding also exhibited the ability to interact with bat p85 (Fig. 5C).
A chimeric bat FLUAV expressing an engineered p85-binding NS1 protein
exhibits cell-type-dependent, but species-independent, propagation phenotypes.
Using reverse genetics, we generated chimeric bat FLUAVs as before (chHL17) but
possessing authentic Guat/09 NS segments expressing either wild-type NS1 (WT) or
NS1-Q96L/T99M (2x), which possesses p85-binding ability with a minimal number of
substitutions. Strikingly, we observed that chHL17-2x exhibited an altered plaque
FIG 4 Engineering the bat FLUAV (Guat/09) NS1 protein to bind p85. (A) Crystal structure of the PR8/NS1 ED in complex
with part of the p85 iSH2 domain. The NS1 ED is shown in gray, with p85 contact residues highlighted in yellow. The
p85 iSH2 domain is colored blue. The six NS1 amino acid residues chosen for mutagenesis studies (see panel B, Guat/09
numbering) are highlighted in red. The ﬁgure was generated using PyMOL with PDB 3L4Q. (B) Comparison of key NS1 ED
residues between human (PR8, Cal09), swine (Sw/Tx/98), avian (Nig/07, Sh/13), and bat (Guat/09, Peru/10) NS1 proteins. #,
Guat/09 numbering. (C and D) 293T cells were cotransfected for 48 h with plasmids expressing the indicated V5-tagged
NS1 protein (or GST) and FLAG-tagged human p85. After cell lysis, clariﬁcation, and anti-V5 immunoprecipitation, soluble
(input) and pulldown (IP:-V5) fractions were analyzed by SDS-PAGE and Western blotting. Data are representative of at
least two independent experiments.
Turkington et al. Journal of Virology
March 2018 Volume 92 Issue 5 e02097-17 jvi.asm.org 6
 o
n
 M
arch 20, 2018 by UNIV DE CO
STA RICA SISTEM
A DE
http://jvi.asm.org/
D
ow
nloaded from
 
phenotype and markedly enhanced propagation capability (100-fold-higher peak
titers) in canine MDCK cells (Fig. 6A and B). Enhanced propagation of the chHL17-2x
virus was also observed, to a lesser extent, in human HAP-1 cells (Fig. 6C). However,
such a phenotype was not found in other cell types: the chHL17-2x virus exhibited
slower replication kinetics in human A549 cells and a subtle attenuation in bat EidNi/41
cells (Fig. 6D and E). These data indicate that the Q96L/T99M substitutions in NS1
impact tissue culture replication of the chimeric bat FLUAV in a cell-type-dependent,
but species-independent, manner.
Role of p85 and PI3K activation in the phenotype of a chimeric bat FLUAV
expressing NS1-Q96L/T99M. We hypothesized that the engineered binding of
Guat/09 NS1-Q96L/T99M to p85, and potential activation of PI3K signaling, was
responsible for modulating propagation of the chHL17-2x virus. However, similar to
expression of the wild-type V5-tagged NS1 protein from Guat/09, expression of V5-
Guat/09 NS1-Q96L/T99M failed to stimulate Akt phosphorylation (Fig. 7A), an observa-
tion supporting previous data that other NS1 determinants beyond efﬁcient p85
binding can critically impact PI3K activation (41, 43, 48). In addition, we assessed
propagation of the chHL17-2x virus in human HAP-1 cells that had been genetically
engineered to lack p85 expression (Fig. 7B). Notably, the chHL17-2x virus also exhib-
ited slightly enhanced propagation in this p85 knockout HAP-1 cell-line (Fig. 7C),
which was similar to the enhancement previously observed in wild-type HAP-1 cells
(Fig. 6C and 7D). Overall, these data suggest that, while the Q96L/T99M substitutions in
Guat/09 NS1 permit host p85-binding, they are not sufﬁcient for this NS1 to activate
host PI3K signaling. Furthermore, these NS1 substitutions may impact propagation of
the chimeric bat FLUAV, at least in some host substrates, in a p85/PI3K-independent
manner.
FIG 5 Engineering the bat FLUAV (Peru/10) NS1 protein to bind p85. (A and B) 293T cells were
cotransfected for 48 h with plasmids expressing the indicated V5-tagged NS1 protein (or GST) and
FLAG-tagged human p85. After cell lysis, clariﬁcation, and anti-V5 immunoprecipitation, soluble (input)
and pulldown (IP:-V5) fractions were analyzed by SDS-PAGE and Western blotting. (C) Experiment
performed as in panel A, except using the indicated bat p85 mutants. Guat/09 3x  Q96L/T99M/R145T;
Peru/10 4x  V96L/T99M/N100I/R145T. For all panels, data are representative of at least two independent
experiments.
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DISCUSSION
Functional characterization of proteins encoded by the novel bat FLUAV sequences
has so far revealed some remarkable properties, most notably that the HA-like protein
does not bind canonical FLUAV sialic acid receptors, and the NA-like protein lacks
neuraminidase activity (7–10). Here, we describe an additional feature of classical
mammalian and avian FLUAVs that is missing in their bat-derived counterparts: the
multifunctional bat FLUAV NS1 virulence factor is unable to bind host p85 or activate
PI3K signaling. This property seems important for the efﬁcient replication of many
classical FLUAV strains in tissue culture and in vivo (38, 43, 44, 47). Using a structure-
guided approach, we found that p85 binding could be engineered into the bat FLUAV
NS1 proteins with a minimum of only two amino acid substitutions (Q96L/T99M) and
that a chimeric bat FLUAV expressing NS1 with these substitutions had improved
propagation kinetics in some tissue culture systems (canine MDCK and human HAP-1)
but a seemingly attenuated phenotype in others (human A549 and bat EidNi/41).
Notably, this disparate impact did not correlate with host species, since two different
human cell lines were identiﬁed in which the outcome of infection was opposite.
Therefore, cell type (and thus unknown differential gene/protein expression proﬁles or
polymorphisms) likely determine the phenotypic result. Interestingly, the propagation
phenotype in human HAP-1 cells of the chimeric bat FLUAV expressing NS1-Q96L/T99M
FIG 6 Characterization of a chimeric bat FLUAV expressing an engineered p85-binding NS1 protein. (A
and B) Plaque phenotype (A) and multicycle growth analysis (B) of chHL17-WT and chHL17-2x viruses in
MDCK cells. (C to E) Multicycle growth analysis of chHL17-WT and chHL17-2x viruses in HAP-1 (C), A549
(D), and EidNi/41 (E) cells. For all growth curves, data represent mean values from three independent
experiments  the standard deviations. Signiﬁcance was calculated using the Student t test comparing
cHL17-WT and chHL17-2x virus titers at each time point (**, P  0.01; *, P  0.05).
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was not diminished in an isogenic cell line completely lacking p85 expression,
suggesting that the amino acid substitutions used to permit p85 binding by NS1 also
modify an additional property of this multifunctional viral protein that has yet to be
identiﬁed. This will certainly be an interesting area to explore in the future and may
impact our understanding of other classical inﬂuenza A viruses and the biological
consequences of certain NS1 polymorphisms that they harbor. Such observations will
also have implications when assessing potential virological consequences of the p85-
binding property arising naturally in bat FLUAVs.
Engineering p85 binding into the bat FLUAV NS1 protein did not result in detect-
able activation of PI3K signaling, indicating that additional regions of NS1 are essential
for this function. Indeed, while p85 binding is necessary for NS1-mediated PI3K
activation (38), our data suggest that it is not sufﬁcient, an observation consistent with
previous work (41, 48). Glutamic acid residues at human FLUAV NS1 positions 96 and
97 (equivalent to bat FLUAV NS1 positions 97 and 98) do not interact directly with
p85, but have been proposed to form part of an “activating interface” with the p110
catalytic subunit of the p85-containing PI3K heterodimer (41). Although these are the
only non-p85-interface residues so far implicated in NS1-activated PI3K signaling, they
are conserved in the bat FLUAV NS1 proteins, meaning that another unidentiﬁed region
of classical FLUAV NS1 proteins must be responsible for ensuring PI3K activation.
Experiments to uncover this speciﬁc region are under way, but it is therefore apparent
that more than the two to four amino acid substitutions required for p85 binding
would be necessary to allow bat FLUAV NS1 proteins to fully acquire PI3K activation
FIG 7 Role of p85 and PI3K activation in the phenotype of a chimeric bat FLUAV expressing NS1-Q96L/
T99M. (A) Serum-starved 1321N1 cells stably expressing the indicated V5-tagged GST or NS1 proteins
were lysed, and the levels of the indicated proteins were analyzed by SDS-PAGE and Western blotting.
(B) Western blot analysis of wild-type or PIK3R2 (p85) knockout HAP-1 cells. For panels A and B, the data
are representative of at least two independent experiments. (C) Multicycle growth analysis of chHL17-WT
and chHL17-2x viruses in PIK3R2 (p85) knockout HAP-1 cells. Data represent mean values from three
independent experiments the standard deviations. (D) Ratios of chHL17-2x to chHL17-WT propagation
titers (represented as area under the curve [AUC] values) in wild-type and PIK3R2 (p85) knockout HAP-1
cells (original data from Fig. 6C and 7C). For panels C and D, the signiﬁcance was calculated using the
Student t test comparing chHL17-WT and chHL17-2x virus titers at each time point (*, P  0.05) or the
AUC ratios in each cell line (ns, nonsigniﬁcant).
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potential, constituting a relatively high genetic barrier to natural evolution of this
property.
Our studies suggest that interactions between NS1 and p85 are not species
speciﬁc: bat FLUAV NS1 proteins do not bind bat p85. Thus, an open question is why
bat FLUAVs have not retained (or evolved) this property like classical mammalian and
avian FLUAVs? One hypothesis for this observation is that the natural host environment
encountered in vivo by bat FLUAVs is in a particular metabolic state such that viral
augmentation of PI3K signaling would not alter host physiology. Indeed, recent ge-
nome sequencing and analysis studies have begun to uncover major differences
between bats and other species and have linked specialized adaptations of bats (e.g.,
ﬂying ability, longevity, hibernation, and echolocation) with speciﬁc adaptive evolution
of energy metabolism genes. Such genes include those involved in oxidative phos-
phorylation (49), insulin/growth factor receptor signaling (50), and DNA damage repair
and apoptosis (51), pathways otherwise known to be regulated by PI3K in many
mammalian systems (52, 53). Possible links between positive selection in bat metabolic
genes and decreased sensitivity to PI3K-mediated regulation need to be validated
experimentally but could account for bat FLUAV NS1 proteins adopting a different
evolutionary path to those from their classical FLUAV counterparts in other species.
Such functional divergence of bat FLUAV NS1 proteins underscores the uniqueness of
these newly discovered viruses and suggests new and intriguing virus-host interaction
biology in bat species that remains to be explored.
MATERIALS AND METHODS
Cells. MDCK (canine), 293T (human), A549 (human), 1321N1 (human), EidNi/41 (bat; Eidolon helvum)
(54), and CarperAEC.B-3 (bat; Carollia perspicillata) (55) cells were cultured in Dulbecco’s modiﬁed Eagle’s
medium (DMEM) supplemented with 10% fetal bovine serum (FBS), 100 U/ml penicillin, and 100 g/ml
streptomycin (Gibco Life Technologies). HAP-1 cells (Horizon Discovery, Austria) were cultured in Iscove’s
modiﬁed Dulbecco’s medium (IMDM) supplemented with the same additives, as well as 200 M
GlutaMAX (Gibco Life Technologies). The HAP-1 cell line engineered by CRISPR/Cas9 to have a 2-bp
deletion in the PIK3R2 gene (encoding p85) was purchased from Horizon Discovery (catalog no.
HZGHC003292c006). All cells were maintained at 37°C with 5% CO2.
Expression plasmids. The NS1 cDNA sequences from A/Swine/Texas/4199-2/98 (Sw/Tx/98, H3N2),
A/Nigeria/OG10/2007 (Nig/07, H5N1), A/Shanghai/2/S1078/2013 (Sh/13, H7N9), A/little yellow shoul-
dered bat/Guatemala/153/2009 (Guat/09, HL17NL10), and A/ﬂat-faced bat/Peru/033/2010 (Peru/10,
HL18NL11) were PCR ampliﬁed from existing plasmids and ligated in frame with an N-terminal V5-tag
into modiﬁed pLVX-IRES-ZsGreen1 or pLVX-IRES-Puro plasmids (Clontech, USA). Similar plasmids express-
ing GST and NS1 sequences from A/Puerto Rico/8/1934 (PR8, H1N1) or A/California/04/09 (Cal09,
pdmH1N1) have been described previously (47). All NS1-encoding cDNAs contained silent mutations in
the splice acceptor site to prevent the expression of NEP. Human p85 and p85 cDNA sequences from
existing plasmids or the bat (Myotis lucifugus) p85 cDNA sequence generated using the GeneArt gene
synthesis service (Thermo Fisher) were PCR ampliﬁed and ligated in frame into p3xFLAG-CMV-7.1
(Sigma-Aldrich) so as to express with N-terminal FLAG tags. Two-step overlap PCR or QuikChange II XL
(Agilent Technologies, Switzerland) was used to introduce site-directed mutations into cDNAs as
required. The identity of all constructs was conﬁrmed by sequencing. All plasmid transfections were
performed using Fugene HD (Promega) at a 1:3 DNA/transfection reagent ratio. As appropriate, gener-
ation of lentiviruses and the production of stable cell lines constitutively expressing proteins of interest
were carried out as previously described (38).
Virus reverse genetics. Plasmids for rescuing chimeric, recombinant HL17NL10 virus (variant C3:
PA-S550R and M2-N31S/T70A) were described previously (14). pHW2000 rescue plasmids comprising the
genome ends and packaging sequences of HL17NL10 and the PR8 HA or NA glycoprotein open reading
frames (ORFs) were generated as described previously (15). Brieﬂy, the untranslated regions of PR8 HA
and NA genome segments were replaced with the genome ends and packaging sequences of the
corresponding segments of HL17NL10 by assembly PCR. Plasmids encoding NS segments where NS1 and
NEP ORFs were separated by the 2A self-cleaving peptide of porcine teschovirus (allowing N-terminal
V5-tagging of NS1) were generated by assembly PCR according to a previous strategy (56). All generated
NS chimeras contained silent mutations in the splice acceptor and donor sites of the ORFs to prevent
aberrant splicing, and duplicated genome packaging sequences were introduced ﬂanking the NS1 ORF
to avoid packaging defects. QuikChange II XL was used to introduce site-directed mutations into cDNAs
as required. For rescues, 6  105 293T cells were seeded in six-well plates and cotransfected 24 h later
with the eight pDZ- or pHW2000-based plasmids. At 24 h posttransfection, the cells were washed once
in sterile phosphate-buffered saline (PBS) and 3  105 MDCK cells were added in DMEM supplemented
with 1 g/ml TPCK (tosylsulfonyl phenylalanyl chloromethyl ketone)-treated trypsin (Sigma-Aldrich, St.
Louis, MO). Forty-eight hours later, the supernatants were harvested, the viruses were plaque puriﬁed,
and virus stocks were grown and titrated according to standard methods in MDCK cells. RNA was
extracted from stock aliquots using a ReliaPrep RNA Cell miniprep system (Promega), and the NS
Turkington et al. Journal of Virology
March 2018 Volume 92 Issue 5 e02097-17 jvi.asm.org 10
 o
n
 M
arch 20, 2018 by UNIV DE CO
STA RICA SISTEM
A DE
http://jvi.asm.org/
D
ow
nloaded from
 
genomic segments of each virus were fully sequenced after segment-speciﬁc RT-PCR to ensure absence
of undesired mutations.
Virus infections. For all infections, viruses were diluted in PBS supplemented with 100 U/ml
penicillin, 100 g/ml streptomycin (Gibco Life Technologies), 0.3% bovine serum albumin (Sigma-
Aldrich), and 1 mM Ca2/Mg2. For HAP-1 cells, cells were seeded onto poly-L-lysine (Sigma-Aldrich)-
coated plates and infected 24 h later at the indicated multiplicity of infection (MOI) for 1 h at 37°C. After
infection, the cells were washed three times and overlaid with FBS-free IMDM. For serum starvation
experiments, the cells were washed three times with FBS-free IMDM and incubated overnight prior to
infection.
For virus growth analyses, cells in 12-well plates were infected with the indicated virus at the
indicated MOI. After infection at 37°C for 1 h, the cells were washed three times with PBS and then
overlaid with DMEM supplemented with 100 U/ml penicillin, 100 g/ml streptomycin (Gibco Life
Technologies), and 0.5 g/ml TPCK-treated trypsin (Sigma-Aldrich). Supernatant samples were harvested
at the indicated time points and stored at 	80°C prior to titration by standard plaque assay.
Sequencing of p85 (PIK3R2) iSH2 domains from bat species. Bats (S. lilium) were captured with
mist nets. Specimens were collected and processed after approval of the Institutional Committee of Care
and Use of Animals of the University of Costa Rica (CICUA-36-13) according to national guidelines for
animal caring described in the Costa Rica National Law for Animal Welfare 7451. For sequencing, 2.5 
105 CarperAEC.B-3 cells seeded in 12-well plates, or an equivalent amount of cellular material from S.
lilium, were lysed and RNA extracted using a ReliaPrep RNA cell miniprep system (Promega). RT-PCR
products were generated and directly sequenced using speciﬁc primers annealing to conserved regions
of PIK3R2 ﬂanking the sequence encoding the p85 iSH2 domain.
Immunoprecipitations. Transfected (2 g total DNA, 48 h in 293T) or infected (MOI of 5 PFU/cell, 8
h in HAP-1) cells in 25-cm2 ﬂasks or six-well plates were lysed on ice in 1 ml of 20 mM Tris-HCl (pH 7.8),
5 mM EDTA, 0.5% (vol/vol) NP-40, and 650 mM NaCl, supplemented with a cOmplete mini protease
inhibitor tablet (Roche, Switzerland). Lysates were clariﬁed using a 29G (0.33-mm) needle and centrifu-
gation at 13,000 rpm for 40 min at 4°C. Soluble fractions were then incubated with 1 g of anti-V5
antibody (Bio-Rad) for 2 h at 4°C prior to further incubation overnight at 4°C with 12.5 l protein
G-Sepharose beads (Sigma-Aldrich). After extensive washing, the remaining proteins were dissociated
from the beads using urea disruption buffer (6 M urea, 1 M -mercaptoethanol, 4% sodium dodecyl
sulfate [SDS]) and heating at 95°C for 10 min. Samples were stored at 	20°C until analysis by SDS-PAGE
and Western blotting.
Akt phosphorylation assays. 1321N1 cells stably expressing the indicated V5-tagged protein were
seeded into 12-well plates and serum starved the following day for 1 h. Cell lysates were harvested in
urea disruption buffer and stored at 	20°C until analysis by SDS-PAGE and Western blotting.
SDS-PAGE and Western blotting. Samples were sonicated to shear nucleic acids and then boiled for
5 min. Polypeptides were resolved by SDS-PAGE on NuPAGE 4-12% Bis-Tris protein gels (Thermo Fisher),
followed by transfer to nitrocellulose membranes (GE Healthcare Life Sciences). Proteins were detected
by Western blotting with the following primary antibodies: mouse anti-V5 (Bio-Rad, MCA1360), mouse
anti-FLAG (Sigma-Aldrich, F3165), mouse anti-p85 (T15; AbD Serotech, MCA1170G), rabbit anti-actin
(Sigma-Aldrich, A2103), rabbit anti-Akt (Cell Signaling Technology, catalog no. 4691), rabbit anti-pAkt
(S473; Cell Signaling Technology, catalog no. 4060), rabbit anti-NS1 (1-73) (57) (kindly provided by Adolfo
García-Sastre, Icahn School of Medicine at Mount Sinai, New York, NY), and rabbit anti-NP (kindly
provided by Silke Stertz, University of Zurich, Zurich, Switzerland). Secondary antibodies were ﬂuoro-
chrome-conjugated: anti-mouse (ThermoFisher Scientiﬁc, SA5-10176) and anti-rabbit (Thermo Fisher
Scientiﬁc, SA5-10036). A LI-COR Odyssey Fc scanner was used for detection.
Structural analyses. Structural representations were visualized using the appropriate PDB ﬁle and
PyMOL (58).
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